Marko Bogoievski
Angel Investor
Wellington, New Zealand
Marko Bogoievski is a funding round investor in Wellington focused on Veterinary and Health Care. Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Marko Bogoievski invests in
Stages Marko Bogoievski invests in
Countries Marko Bogoievski invests in
Investment Focus
Industry
- Veterinary 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Manufacturing 1 (33%)
- Product Design 1 (33%)
Stage
- Funding Round 1 (33%)
- Convertible Note 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pictor
|
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for human and animal health which provides highly accurate, sensitive and efficient testing of multiple complex and infectious diseases simultaneously per sample. The company was founded in 2006 and is headquartered in Parnell, Auckland, New Zealand, withsubsidiaries in the USA and in India. | $5M / Dec 04, 2022 | |
|
Pictor
|
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for human and animal health which provides highly accurate, sensitive and efficient testing of multiple complex and infectious diseases simultaneously per sample. The company was founded in 2006 and is headquartered in Parnell, Auckland, New Zealand, withsubsidiaries in the USA and in India. | $6.1M / Apr 13, 2022 | |
|
Pictor
|
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for human and animal health which provides highly accurate, sensitive and efficient testing of multiple complex and infectious diseases simultaneously per sample. The company was founded in 2006 and is headquartered in Parnell, Auckland, New Zealand, withsubsidiaries in the USA and in India. | Convertible Note |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Marko Bogoievski invest in?
Marko Bogoievski invests primarily in Veterinary, Health Care and Biotechnology startups, most often at Funding Round and Convertible Note stage. Most of the 3 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Marko Bogoievski last invest?
The most recent investment recorded for Marko Bogoievski closed in Dec 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
